Please use this identifier to cite or link to this item:
Title: Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: Systematic review
Authors: Andjelkovic, Marija
Jankovic, Slobodan
Kostic M.
Zivkovic-Zaric R.
Opancina, Valentina
Živić, Miloš
Milosavljevic, Marko
Pejcic, Ana
Issue Date: 2019
Abstract: © 2019, © 2019 Edizioni Scientifi che per l'Informazione su Farmaci e Terapia. Stenotrophomonas maltophilia can cause serious infections in immunocompromised patients. The aim of this systematic review was to establish what invasive infections in humans are caused by S. maltophilia and to evaluate the optimal choice of antibiotics for their treatment. MEDLINE, EBSCO, SCOPUS, SCINDEKS and GOOGLE SCHOLAR were systematically searched for clinical trials, observational studies, case reports or case series describing invasive infections with S. maltophilia in patients of any age. S. maltophilia may cause invasive infections of various tissues in hospitalized patients. In the great majority of cases it was susceptible to co-trimoxazole, levofloxacin and ceftazidime. In about three fourths of the cases, the treatment was successful, while less than 20% of the patients died. S. maltophilia is increasingly associated with serious invasive infections in hospitalized patients and due to growing trend of resistance to almost all antibiotics requires a careful approach to patients who is harboring this bacterium.
Type: review
DOI: 10.1080/1120009X.2019.1620405
ISSN: 1120-009X
SCOPUS: 2-s2.0-85072508358
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)




Files in This Item:
File Description SizeFormat 
  Restricted Access
29.86 kBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.